Skip to content
Immunophotonics
  • About
    • Team
    • Board of Directors
    • Advisory Board
    • Highlighted Co-Inventor
    • Collaborators
  • Technology
  • Interventional Immuno-Oncology®
  • Clinical Trials
    • Colorectal Cancer (CRC)
    • Non-Small Cell Lung Cancer (NSCLC)
    • Melanoma
    • Soft Tissue Sarcoma (STS)
    • Hepatocellular Carcinoma (HCC)
    • Pancreatic Cancer
    • Vaccine Adjuvant
  • Patients
  • News & Media
  • Contact Us
Menu

News

404

News & Media

  •          
  • Print
Home » News & Media
Latest News

Volunteering at World Wide Technology American Cancer Society Hope Lodge

July 9, 2025
The Immunophotonics team had the privilege of volunteering at the World Wide Technology American Cancer Society Hope Lodge in St.…
Read More
Latest News

Immunophotonics Event May 7th

July 9, 2025
A Heartfelt Thank You to Our Event Attendees. We extend our gratitude to everyone who attended our event last night.…
Read More
Latest News

Swiss Biotech Day May 5-6, 2025

July 9, 2025
Immunophotonics is thrilled to share that Dr. Theresa Visarius from Immunophotonics Switzerland (IPS Biopharma AG) will be presenting at the Swiss Biotech Days 2025 in…
Read More
Latest News

LSX World Congress Europe April 28–30, 2025

July 9, 2025
Immunophotonics is excited to share that Dr. Theresa Visarius, VP Business Development will be attending the LSX World Congress Europe…
Read More
Latest News

AACR April 25-30, 2025

April 22, 2025
Tomas Hode, PhD, CIO & President will be attending the American Association of Cancer Research (AACR) annual meeting April 25-30,…
Read More
Latest News Press Releases

Jacqueline Hess Joins Immunophotonics Board of Directors

April 16, 2025
Immunophotonics, Inc. has strengthened its leadership team with the appointment of Jacqueline Hess to its Board of Directors.  With over…
Read More
Latest News

ECIO April 13–16, 2025

April 9, 2025
Diane Beatty, PhD, VP of Regulatory and Clinical Affairs, and Kelly Porterfield, Director of Clinical Operations, will be participating in…
Read More
Latest News

University of Oklahoma Entrepreneurial Seminar Series April 4, 2025

April 2, 2025
Lu Alleruzzo, CEO and Tomas Hode, PhD, President & CIO were honored to be invited to present at the Entrepreneurial…
Read More
Latest News

AngioDynamics International Life Symposium Barcelona Spain March 27 – 29, 2025

March 26, 2025
Tomas Hode, PhD, Co-Founder, CIO, and President of Immunophotonics will be attending the AngioDynamics International Life Symposium from March 27th…
Read More
Latest News

MedInvest Biotech and Pharma Investor Conference March 27 – 28, 2025

March 25, 2025
Lu Alleruzzo, CEO and Robert Arch, SVP Corporate Development at Immunophotonics, Inc. are attending the MedInvest Biotech and Pharma Investor conference…
Read More
« Previous 1 2 3 4 5 6 … 14 Next »
Contact us for more info and updates
  • About
  • Team
  • Board of Directors
  • Advisory Board
  • Highlighted Co-Inventor
  • Collaborators
  • Technology
  • Clinical Trials
  • Colorectal Cancer (CRC)
  • Non-Small Cell Lung Cancer (NSCLC)
  • Melanoma
  • Soft Tissue Sarcoma (STS)
  • Hepatocellular Carcinoma (HCC)
  • Pancreatic Cancer
  • Vaccine Adjuvant
  • Patients
  • Background
  • Trial Summary

Quick Links

  • Interventional Immuno-Oncology®
  • News & Media
  • Careers
  • Contact Us
  • Privacy Policy
  • Site Map
© Immunophotonics, Inc. All Rights Reserved
Terms of Use | FCOI Policy
Website by Axxiem
Scroll to top